2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products – GH Research (NASDAQ:GHRS), PharmaTher Holdings (OTC:PHRRF)
[ad_1] Two psychedelics companies have shared their updates and key milestones to be reached this 2023. The 5-MeO-DMT Business Clinical-stage biopharma company GH Research PLC GHRS has received initial regulatory…